Gebhardt, Thomas http://orcid.org/0000-0002-3768-9468
Park, Simone L.
Parish, Ian A. http://orcid.org/0000-0003-3528-478X
Article History
Accepted: 11 August 2023
First Online: 11 October 2023
Competing interests
: T.G. is a scientific advisory board member of oNKo Innate Pty. Ltd and has received research funding from Merck Healthcare KGaA. I.A.P. receives research funding from AstraZeneca and Bristol-Myers Squibb. S.L.P. declares no competing interests.